Table 3 Study baseline and outcome characteristics
Baseline characteristics | Ouyang et al |
|---|---|
Country | China |
No. of participants | 2300 |
Median follow-up | 2.5 years |
Death (%) | 10 (0.4) |
Median age (IQR) | 35 years (28–44) |
Male (%) | 1,106 (48.1%) |
Creatinine at biopsy — median (IQR) µmol/l | 95 (74–134) |
eGFR at biopsy — median (IQR) (ml/min/1.73 m2) | 76.9 (50.1–103.6) |
MAP at biopsy — median (IQR) (mmHg) | 96.3 mmHg (88.3–105.7) |
Proteinuria at biopsy — median (IQR)(g/d) | 1.3 (0.7–2.6) |
Primary outcome | |
50% decline in eGFR (%) | 264 (11.5) |
ESRD (%) | 214 (9.3) |
Total primary outcome (%) | 288 (12.5) |